Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections

被引:22
|
作者
Madani, Yasser [1 ]
Mann, Bhupinder [1 ]
机构
[1] W Middlesex Univ Hosp, Dept Resp Med, London TW7 6AF, England
来源
PRIMARY CARE RESPIRATORY JOURNAL | 2012年 / 21卷 / 03期
关键词
nitrofurantoin; lung disease; drug-induced; fibrosis; urinary tract infection; prophylaxis; PULMONARY-FIBROSIS;
D O I
10.4104/pcrj.2012.00059
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Nitrofurantoin is commonly used for the treatment and prophylaxis of recurrent urinary tract infections (UTIs). Although relatively rare, nitrofurantoin is one of the commonest causes of drug-induced pulmonary disease, which can be potentially serious and even fatal. Knowledge of such potential adverse effects is essential to enable early recognition and withdrawal of the drug. Patients on long-term nitrofurantoin should be reviewed and monitored regularly. Management involves early consideration of the condition, and prompt withdrawal of the drug. We report three cases of nitrofurantoin-induced lung disease in patients who were on long-term nitrofurantoin for UTI prophylaxis and present a brief review of the literature on this subject. (C) 2012 Primary Care Respiratory Society UK. All rights reserved. Y Madani and B Mann. Prim Care Respir J 2012; 21(3): 337-341 http://dx.doi.org/10.4104/pcrj.2012.00059
引用
收藏
页码:337 / 341
页数:5
相关论文
共 50 条
  • [1] Re: Nitrofurantoin-Induced Lung Disease and Prophylaxis of Urinary Tract Infections Editorial Comment
    Madani, Y.
    Mann, B.
    JOURNAL OF UROLOGY, 2013, 190 (04): : 1252 - 1252
  • [2] NITROFURANTOIN-INDUCED INTERSTITIAL LUNG DISEASE: WHEN URINARY TRACT INFECTION PROPHYLAXIS GOES WRONG
    Springsted, Elspeth
    Giri, Badri
    CHEST, 2021, 160 (04) : 1206A - 1206A
  • [3] Chronic nitrofurantoin-induced lung disease
    Mendez, JL
    Nadrous, HF
    Hartman, TE
    Ryu, JH
    MAYO CLINIC PROCEEDINGS, 2005, 80 (10) : 1298 - 1302
  • [4] Nitrofurantoin-induced interstitial lung disease
    Basunaid, Suhail
    Schoutteten, M.
    Pilate, H.
    Sprooten, R.
    Rohde, Gernot
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [5] Nitrofurantoin-induced interstitial lung disease
    Lin, Daniel Chou-yen
    Bhally, Hasan
    NEW ZEALAND MEDICAL JOURNAL, 2007, 120 (1263) : 56 - 59
  • [6] NITROFURANTOIN-INDUCED LUNG-DISEASE IN SWEDEN
    HOLMBERG, L
    BOMAN, G
    BRITISH JOURNAL OF DISEASES OF THE CHEST, 1979, 73 (04): : 419 - 420
  • [7] Why Is This 70-year-old Drug Still Being Prescribed for Urinary Tract Infections? A Case of Nitrofurantoin-induced Interstitial Lung Disease
    Park, C.
    Evans, S. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [8] IMMUNOLOGICAL STUDIES OF NITROFURANTOIN-INDUCED LUNG-DISEASE
    JANICKI, BW
    GOLDSTEIN, RA
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1974, 109 (06): : 732 - 733
  • [9] Factors predicting resolution in nitrofurantoin-induced lung disease
    Creamer, Andrew
    Abdullah, Rezaur
    Jameel, Ayesha
    Hare, Sam
    Vancheeswaran, Rama
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [10] BRONCHOALVEOLAR LAVAGE IN NITROFURANTOIN-INDUCED LUNG-DISEASE
    AKOUN, GM
    MILLERON, B
    ELGHARBI, N
    MALKA, M
    SEMAINE DES HOPITAUX, 1985, 61 (33): : 2443 - 2446